Ipsen signs agreement to acquire Octreopharm Sciences
20 May 2015 | By Victoria White
Ipsen signed an agreement to acquire OctreoPharm Sciences, a life sciences company focusing on the development of innovative radioactive labelled compounds...
List view / Grid view
News
Mucosis to present data on intranasal RSV vaccine SynGEM at MVADS 2015
19 May 2015 | By Victoria White
Dr Leenhouts is set to discuss the progress with Mucosis' intranasal respiratory syncytial virus (RSV) vaccine candidate, SynGEM, at MVADS 2015...
Genmab and BioNTech sign co-development agreement in immuno-oncology
19 May 2015 | By Victoria White
BioNTech has signed an agreement with Genmab to jointly research, develop and commercialise multiple bispecific antibodies for cancer immunotherapy...
Scientists discover why Streptococcus pneumoniae infections can cause fatal heart complications
19 May 2015 | By Victoria White
Researchers have discovered a key cause of life threatening heart complications, conditions that frequently follow severe Streptococcus pneumoniae infection..
Broad Institute receives $10 million from the Gerstner Family Foundation to research cancer drug resistance
18 May 2015 | By Victoria White
Broad Institute of MIT and Harvard are to receive a $10 million gift from the Gerstner Family Foundation that will expand cancer research...
Anavex releases preclinical anti-seizure data for ANAVEX 2-73
18 May 2015 | By Victoria White
Anavex revealed full preclinical anti-seizure data for its lead drug candidate, ANAVEX 2-73, at the Antiepileptic Drug Trials XIII Conference...
Ablynx and Genzyme to collaborate on multiple sclerosis research project
18 May 2015 | By Victoria White
Ablynx is set to collaborate with Genzyme to investigate Nanobodies against a target that plays an important role in multiple sclerosis (MS)...
Contraceptive and cholesterol-lowering drug combination (BaP) used to treat cancer
15 May 2015 | By Victoria White
The BaP combination of a cholesterol-lowering drug, bezafibrate and a contraceptive steroid could be an effective treatment for a range of cancers.
Lilly and Sanford-Burnham to collaborate to discover immunological therapies
15 May 2015 | By Victoria White
Eli Lilly and Company and Sanford-Burnham Medical Research Institute are to collaborate to discover and develop immunological therapies...
Anisina confirmed as effective anti-cancer agent in preclinical studies
14 May 2015 | By Victoria White
Novogen has confirmed that drug candidate, Anisina, is an effective monotherapy against human melanoma in an animal model...
Acucela announces publication of preclinical data for emixustat
14 May 2015 | By Victoria White
Acucela has announced the publication of preclinical data related to the Company’s investigational drug candidate emixustat hydrochloride...
Antibiotic Research UK welcomes the O’Neill Commission’s recommendation to create $2b global fund to tackle antibiotic resistance
14 May 2015 | By Victoria White
Antibiotic Research UK has welcomed this latest report to come from Jim O’Neill's Review on Antimicrobial Resistance and has endorses its recommendations...
Immunomic Therapeutics awarded $1.2m to develop peanut allergy treatment
13 May 2015 | By Victoria White
Immunomic Therapeutics has been awarded a US $1.2 million grant for the development of its ARA-LAMP-vax technology against peanut allergies...
Sanofi exercises option on second therapeutic programme with Selecta Biosciences to develop a treatment for coeliac disease
13 May 2015 | By Victoria White
Under the terms of an existing agreement with Selecta, Sanofi has exercised its option to an exclusive license to develop a treatment of coeliac disease...
Genethon and Selecta Biosciences to research repeat dosing for gene therapies
13 May 2015 | By Victoria White
Genethon and Selecta Biosciences have announced an ongoing research collaboration with the goal of enabling repeat dosing for gene therapies...
